Leonard Greenstein
2023
In 2023, Leonard Greenstein earned a total compensation of $2M as Chief Financial Officer at Tarsus Pharmaceuticals.
Compensation breakdown
Non-Equity Incentive Plan | $71,552 |
---|---|
Option Awards | $893,298 |
Salary | $202,100 |
Stock Awards | $411,746 |
Other | $399,883 |
Total | $1,978,579 |
Greenstein received $893.3K in option awards, accounting for 45% of the total pay in 2023.
Greenstein also received $71.6K in non-equity incentive plan, $202.1K in salary, $411.7K in stock awards and $399.9K in other compensation.
Rankings
In 2023, Leonard Greenstein's compensation ranked 514th out of 2,647 executives tracked by ExecPay. In other words, Greenstein earned more than 80.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 514 | 81st |
Manufacturing | 295 | 80th |
Chemicals And Allied Products | 207 | 75th |
Drugs | 204 | 74th |
Biological Products, Except Diagnostic Substances | 73 | 64th |
Greenstein's colleagues
We found three more compensation records of executives who worked with Leonard Greenstein at Tarsus Pharmaceuticals in 2023.